166 related articles for article (PubMed ID: 19121544)
1. Aminoacid-derivatised picolinato-oxidovanadium(IV) complexes: characterisation, speciation and ex vivo insulin-mimetic potential.
Esbak H; Enyedy EA; Kiss T; Yoshikawa Y; Sakurai H; Garribba E; Rehder D
J Inorg Biochem; 2009 Apr; 103(4):590-600. PubMed ID: 19121544
[TBL] [Abstract][Full Text] [Related]
2. A new family of insulin-mimetic vanadium complexes derived from 5-carboalkoxypicolinates.
Gätjens J; Meier B; Kiss T; Nagy EM; Buglyó P; Sakurai H; Kawabe K; Rehder D
Chemistry; 2003 Oct; 9(20):4924-35. PubMed ID: 14562311
[TBL] [Abstract][Full Text] [Related]
3. Bis- and tris(pyridyl)amine-oxidovanadium complexes: characteristics and insulin-mimetic potential.
Nilsson J; Degerman E; Haukka M; Lisensky GC; Garribba E; Yoshikawa Y; Sakurai H; Enyedy EA; Kiss T; Esbak H; Rehder D; Nordlander E
Dalton Trans; 2009 Oct; (38):7902-11. PubMed ID: 19771353
[TBL] [Abstract][Full Text] [Related]
4. Aqueous chemistry of the vanadium(III) (V(III)) and the V(III)-dipicolinate systems and a comparison of the effect of three oxidation states of vanadium compounds on diabetic hyperglycemia in rats.
Buglyó P; Crans DC; Nagy EM; Lindo RL; Yang L; Smee JJ; Jin W; Chi LH; Godzala Iii ME; Willsky GR
Inorg Chem; 2005 Jul; 44(15):5416-27. PubMed ID: 16022540
[TBL] [Abstract][Full Text] [Related]
5. Salicylamide and salicylglycine oxidovanadium complexes with insulin-mimetic properties.
Nilsson J; Shteinman AA; Degerman E; Enyedy EA; Kiss T; Behrens U; Rehder D; Nordlander E
J Inorg Biochem; 2011 Dec; 105(12):1795-800. PubMed ID: 22056176
[TBL] [Abstract][Full Text] [Related]
6. A novel drug delivery system for type 1 diabetes: insulin-mimetic vanadyl-poly(gamma-glutamic acid) complex.
Karmaker S; Saha TK; Yoshikawa Y; Yasui H; Sakurai H
J Inorg Biochem; 2006 Sep; 100(9):1535-46. PubMed ID: 16824605
[TBL] [Abstract][Full Text] [Related]
7. In vivo coordination structural changes of a potent insulin-mimetic agent, bis(picolinato)oxovanadium(IV), studied by electron spin-echo envelope modulation spectroscopy.
Fukui K; Fujisawa Y; OhyaNishiguchi H; Kamada H; Sakurai H
J Inorg Biochem; 1999; 77(3-4):215-24. PubMed ID: 10643660
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of insulin-mimetic activities of vanadyl and zinc(II) complexes from the viewpoint of heterocyclic bidentate ligands.
Katoh A; Matsumura Y; Yoshikawa Y; Yasui H; Sakurai H
J Inorg Biochem; 2009 Apr; 103(4):567-74. PubMed ID: 19162327
[TBL] [Abstract][Full Text] [Related]
9. New developments in the comprehension of the biotransformation and transport of insulin-enhancing vanadium compounds in the blood serum.
Sanna D; Micera G; Garribba E
Inorg Chem; 2010 Jan; 49(1):174-87. PubMed ID: 19947643
[TBL] [Abstract][Full Text] [Related]
10. Bis(allixinato)oxovanadium(IV) complex is a potent antidiabetic agent: studies on structure-activity relationship for a series of hydroxypyrone-vanadium complexes.
Adachi Y; Yoshida J; Kodera Y; Katoh A; Takada J; Sakurai H
J Med Chem; 2006 Jun; 49(11):3251-6. PubMed ID: 16722643
[TBL] [Abstract][Full Text] [Related]
11. Chloro-substituted dipicolinate vanadium complexes: synthesis, solution, solid-state, and insulin-enhancing properties.
Smee JJ; Epps JA; Ooms K; Bolte SE; Polenova T; Baruah B; Yang L; Ding W; Li M; Willsky GR; la Cour A; Anderson OP; Crans DC
J Inorg Biochem; 2009 Apr; 103(4):575-84. PubMed ID: 19201030
[TBL] [Abstract][Full Text] [Related]
12. Oxidation of p-chlorotoluene and cyclohexene catalysed by polymer-anchored oxovanadium(IV) and copper(II) complexes of amino acid derived tridentate ligands.
Maurya MR; Kumar M; Kumar A; Costa Pessoa J
Dalton Trans; 2008 Aug; (32):4220-32. PubMed ID: 18682861
[TBL] [Abstract][Full Text] [Related]
13. Syntheses of vanadyl and zinc(II) complexes of 1-hydroxy-4,5,6-substituted 2(1H)-pyrimidinones and their insulin-mimetic activities.
Yamaguchi M; Wakasugi K; Saito R; Adachi Y; Yoshikawa Y; Sakurai H; Katoh A
J Inorg Biochem; 2006 Feb; 100(2):260-9. PubMed ID: 16387366
[TBL] [Abstract][Full Text] [Related]
14. Novel 3-hydroxy-4-pyridinonato oxidovanadium(IV) complexes to investigate structure/activity relationships.
Rangel M; Amorim MJ; Nunes A; Leite A; Pereira E; de Castro B; Sousa C; Yoshikawa Y; Sakurai H
J Inorg Biochem; 2009 Apr; 103(4):496-502. PubMed ID: 19195710
[TBL] [Abstract][Full Text] [Related]
15. Comparative studies on the biospeciation of antidiabetic VO(IV) and Zn(II) complexes.
Kiss T; Jakusch T; Hollender D; Enyedy EA; Horváth L
J Inorg Biochem; 2009 Apr; 103(4):527-35. PubMed ID: 19114286
[TBL] [Abstract][Full Text] [Related]
16. Novel vanadyl complexes with quinoxaline N(1),N(4)-dioxide derivatives as potent in vitro insulin-mimetic compounds.
Noblía P; Vieites M; Torre MH; Costa-Filho AJ; Cerecetto H; González M; Lavaggi ML; Adachi Y; Sakurai H; Gambino D
J Inorg Biochem; 2006 Feb; 100(2):281-7. PubMed ID: 16386797
[TBL] [Abstract][Full Text] [Related]
17. Interaction of VO2+ ion and some insulin-enhancing compounds with immunoglobulin G.
Sanna D; Micera G; Garribba E
Inorg Chem; 2011 Apr; 50(8):3717-28. PubMed ID: 21434616
[TBL] [Abstract][Full Text] [Related]
18. Biospeciation of various antidiabetic V(IV)O compounds in serum.
Jakusch T; Hollender D; Enyedy EA; González CS; Montes-Bayón M; Sanz-Medel A; Costa Pessoa J; Tomaz I; Kiss T
Dalton Trans; 2009 Apr; (13):2428-37. PubMed ID: 19290378
[TBL] [Abstract][Full Text] [Related]
19. Speciation of potential anti-diabetic vanadium complexes in real serum samples.
Sanna D; Ugone V; Serra M; Garribba E
J Inorg Biochem; 2017 Aug; 173():52-65. PubMed ID: 28499214
[TBL] [Abstract][Full Text] [Related]
20. Structure-dependent metallokinetics of antidiabetic vanadyl-picolinate complexes in rats: studies on solution structure, insulinomimetic activity, and metallokinetics.
Yasui H; Tamura A; Takino T; Sakurai H
J Inorg Biochem; 2002 Jul; 91(1):327-38. PubMed ID: 12121792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
